TrademarkOpen
Search / United States / 90590474

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Service Mark

SKYSEQ

Registered
Used for: Research and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and…
Show more

Research and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases using integrated and high-throughput screening technologies coupled with next-generation sequencing

Class 42 – Technology & SaaS

Status timeline

  1. 23 Mar 2021
    Application filed
    New Application Entered
  2. 21 Oct 2021
    Assigned to an examining attorney
    Assigned To Examiner
  3. 26 Apr 2022
    Response to office action filed
    Teas Response To Office Action Received
  4. 1 Jun 2022
    Approved for publication
    Approved For Pub - Principal Register
  5. 5 Jul 2022
    Published for opposition
    Published For Opposition
  6. 30 Aug 2022
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  7. 22 Feb 2023
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  8. 21 Aug 2023
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  9. 19 Feb 2024
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
  10. 28 May 2024
    Statement of use filed
    Teas Statement Of Use Received
  11. 18 Oct 2024
    Office action issued
    Non-Final Action Written
  12. 24 Oct 2024
    Response to office action filed
    Teas Response To Office Action Received
  13. 20 Mar 2025
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  14. 8 Apr 2025
    Registered on the Principal Register
    Registered-Principal Register
All 42 events
2025-04-08Registered-Principal Register
2025-04-08Notice Of Registration Confirmation Emailed
2025-03-20Allowed Principal Register - Sou Accepted
2025-03-20Notice Of Acceptance Of Statement Of Use E-Mailed
2024-11-01Assigned To Lie
2024-11-01Correspondence Received In Law Office
2024-11-01Teas/Email Correspondence Entered
2024-10-24Teas Response To Office Action Received
2024-10-18Non-Final Action Written
2024-10-18Non-Final Action E-Mailed
2024-10-18Notification Of Non-Final Action E-Mailed
2024-08-27Sou Teas Extension Received
2024-07-06Case Assigned To Intent To Use Paralegal
2024-07-06Statement Of Use Processing Complete
2024-05-28Teas Statement Of Use Received
2024-05-28Use Amendment Filed
2024-02-20Notice Of Approval Of Extension Request E-Mailed
2024-02-19Sou Teas Extension Received
2024-02-19Sou Extension 3 Filed
2024-02-19Sou Extension 3 Granted
2023-08-23Notice Of Approval Of Extension Request E-Mailed
2023-08-21Sou Teas Extension Received
2023-08-21Sou Extension 2 Filed
2023-08-21Sou Extension 2 Granted
2023-02-24Notice Of Approval Of Extension Request E-Mailed
2023-02-22Sou Teas Extension Received
2023-02-22Sou Extension 1 Filed
2023-02-22Sou Extension 1 Granted
2022-08-30Noa Mailed - Sou Required From Applicant
2022-07-05Published For Opposition
2022-07-05Official Gazette Publication Confirmation E-Mailed
2022-06-15Notification Of Notice Of Publication E-Mailed
2022-06-01Approved For Pub - Principal Register
2022-04-26Teas Response To Office Action Received
2022-04-26Correspondence Received In Law Office
2022-04-26Teas/Email Correspondence Entered
2021-10-27Priority Action Written
2021-10-27Priority Action E-Mailed
2021-10-27Notification Of Priority Action E-Mailed
2021-10-21Assigned To Examiner
2021-06-22New Application Office Supplied Data Entered
2021-03-23New Application Entered

Goods & services by class

Class 42 Technology & SaaS

Research and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases using integrated and high-throughput screening technologies coupled with next-generation sequencing

First use anywhere 8 Apr 2024 · First use in commerce 8 Apr 2024

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 8 Apr 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.